Purification and characterization of insulin-mimetic inositol phosphoglycan-like molecules from grass pea (Lathyrus sativus) seeds

被引:10
作者
Pañeda, C
Villar, AV
Alonso, A
Goñi, FM
Varela, F
Brodbeck, U
León, Y
Varela-Nieto, I
Jones, DR
机构
[1] CSIC, Inst Invest Biomed Alberto Sols, Madrid 28029, Spain
[2] Univ Basque Country, Unidad Biofis, CSIC, EHU, E-48080 Bilbao, Spain
[3] Univ Basque Country, Dept Bioquim, E-48080 Bilbao, Spain
[4] INIA, CRF, Madrid, Spain
[5] Univ Bern, Inst Biochem & Mol Biol, Bern, Switzerland
[6] CSIC, Ctr Nacl Biotecnol, Dept Immunol & Oncol, Madrid, Spain
关键词
D O I
10.1007/BF03401850
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Background: Signal transduction through the hydrolysis of glycosyl-phosphatidylinositol (GPI) leading to the release of the water-soluble inositol phosphoglycan (IPG) molecules has been demonstrated to be important for mediating some of the actions of insulin and insulin-like growth factor-I (IGF-I). Materials and Methods: in the present study, GPI from grass pea (Lathyrus sativus) seeds has been purified and partially characterized on the basis of its chromatographic properties and its compositional analysis. Results: The results indicate that it shows similarities to GPI previously isolated from other sources such as rat liver. IPG was generated from L. sativus seed GPI by hydrolysis with a GPI-specific phospholipase D (GPI-PLD). This IPG inhibited protein kinase A (PKA) in an in vitro assay, caused cell proliferation in explanted cochleovestibular ganglia (CVG), and decreased 8-Br-cAMP-induced phosphoenolpyruvate carboxykinase (PEPCK) mRNA expression in cultured hepatoma cells. Conclusions: Our data indicate that L. sativus seed IPG possess insulin-mimetic activities. This may explain why L. sativus seeds have been used in some traditional medicines to ameliorate diabetic symptoms.
引用
收藏
页码:454 / 460
页数:7
相关论文
共 40 条
  • [21] 2-1
  • [22] INSULIN-LIKE GROWTH-FACTOR-I REGULATES CELL-PROLIFERATION IN THE DEVELOPING INNER-EAR, ACTIVATING GLYCOSYL-PHOSPHATIDYLINOSITOL HYDROLYSIS AND FOS EXPRESSION
    LEON, Y
    VAZQUEZ, E
    SANZ, C
    VEGA, JA
    MATO, JM
    GIRALDEZ, F
    REPRESA, J
    VARELANIETO, I
    [J]. ENDOCRINOLOGY, 1995, 136 (08) : 3494 - 3503
  • [23] Involvement of insulin-like growth factor-I in inner ear organogenesis and regeneration
    León, Y
    Sanz, C
    Frago, LM
    Camarero, G
    Cañón, S
    Varela-Nieto, I
    Giráldez, F
    [J]. HORMONE AND METABOLIC RESEARCH, 1999, 31 (2-3) : 126 - 132
  • [24] Martín-Lomas M, 2000, CHEM-EUR J, V6, P3608, DOI 10.1002/1521-3765(20001002)6:19<3608::AID-CHEM3608>3.0.CO
  • [25] 2-Q
  • [26] McConville MJ, 2000, MOL MEMBR BIOL, V17, P1
  • [27] NARAYANAN CR, 1987, CURR SCI INDIA, V56, P139
  • [28] A new glycoside, 1D-2-O-alpha-D-galactopyranosyl-chiro-inositol from jojoba beans
    Ogawa, K
    Watanabe, T
    Ikeda, Y
    Kondo, S
    [J]. CARBOHYDRATE RESEARCH, 1997, 302 (3-4) : 219 - 221
  • [29] GLYCOSYL-PHOSPHATIDYLINOSITOL INOSITOL PHOSPHOGLYCAN - A SIGNALING SYSTEM FOR THE LOW-AFFINITY NERVE GROWTH-FACTOR RECEPTOR
    REPRESA, J
    AVILA, MA
    MINER, C
    GIRALDEZ, F
    ROMERO, G
    CLEMENTE, R
    MATO, JM
    VARELANIETO, I
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (18) : 8016 - 8019
  • [30] RUBENSTEIN AH, 1962, LANCET, V2, P1348